PhotonPharma installs new CEO as ovarian-cancer drug trial launches

PhotonPharma Inc., which specializes in tumor-specific immune therapies, has hired Derek Brown as its new CEO as the company prepares to launch a trial of its ovarian-cancer drug candidate.
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Already have a paid subscription?